Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 9/2014

01-09-2014 | Article

Estimating the prevalence of coinfection with influenza virus and the atypical bacteria Bordetella pertussis, Chlamydophila pneumoniae, and Mycoplasma pneumoniae

Authors: M. J. Mina, R. M. Burke, K. P. Klugman

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 9/2014

Login to get access

Abstract

Coinfections with common bacterial respiratory pathogens and influenza viruses are well-known causes of disease, often via synergistic interactions between the influenza virus, the bacteria, and the human host. However, relatively little is known about interactions between atypical bacteria and influenza viruses. A recent report by Reinton et al. explored this issue by analyzing data from 3,661 patients seeking medical assistance for the presence of Mycoplasma pneumoniae, Chlamydophila pneumoniae, and Bordetella pertussis, as well as influenza A or B virus in nasal swab specimens. The report, however, did not accurately assess the epidemiologic interactions of these pathogens. We aimed to describe the interactions between these bacterial species and influenza infections. Strong and highly statistically significant antagonistic interspecies interactions were detected between C. pneumoniae and influenza virus [odds ratio (OR): 0.09; p < 0.0001) and M. pneumoniae and influenza virus infections (OR: 0.29; p = 0.003). No association was detected between B. pertussis and influenza infection (p = 0.34), contrary to the initial report, and coinfection was not detected at a higher-than-by-chance frequency within the population. Further support of these results is supplied by the analysis of two earlier investigations reporting data on influenza virus and these atypical bacteria. Our results supplement the large body of literature regarding interactions between influenza virus and typical respiratory pathogens, providing a fuller picture of the spectrum of interactions between influenza viruses and respiratory bacteria. Further, we demonstrate the importance of choosing the most appropriate reference populations for the analysis being performed and describe the pitfalls that may occur when care is not taken in this regard.
Appendix
Available only for authorised users
Literature
1.
go back to reference Morens DM, Taubenberger JK, Fauci AS (2008) Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 198(7):962–970PubMedCentralPubMedCrossRef Morens DM, Taubenberger JK, Fauci AS (2008) Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 198(7):962–970PubMedCentralPubMedCrossRef
3.
go back to reference Centers for Disease Control and Prevention (CDC) (2009) Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1)—United States, May–August 2009. MMWR Morb Mortal Wkly Rep 58(38):1071–1074 Centers for Disease Control and Prevention (CDC) (2009) Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1)—United States, May–August 2009. MMWR Morb Mortal Wkly Rep 58(38):1071–1074
4.
go back to reference Centers for Disease Control and Prevention (CDC) (2012) Severe coinfection with seasonal influenza A (H3N2) virus and Staphylococcus aureus—Maryland, February–March 2012. MMWR Morb Mortal Wkly Rep 61(16):289–291 Centers for Disease Control and Prevention (CDC) (2012) Severe coinfection with seasonal influenza A (H3N2) virus and Staphylococcus aureus—Maryland, February–March 2012. MMWR Morb Mortal Wkly Rep 61(16):289–291
5.
go back to reference Redford PS, Mayer-Barber KD, McNab FW, Stavropoulos E, Wack A, Sher A, O’Garra A (2014) Influenza A virus impairs control of Mycobacterium tuberculosis coinfection through a type I interferon receptor-dependent pathway. J Infect Dis 209(2):270–274PubMedCentralPubMedCrossRef Redford PS, Mayer-Barber KD, McNab FW, Stavropoulos E, Wack A, Sher A, O’Garra A (2014) Influenza A virus impairs control of Mycobacterium tuberculosis coinfection through a type I interferon receptor-dependent pathway. J Infect Dis 209(2):270–274PubMedCentralPubMedCrossRef
6.
go back to reference Waki N, Yajima N, Suganuma H, Buddle BM, Luo D, Heiser A, Zheng T (2014) Oral administration of Lactobacillus brevis KB290 to mice alleviates clinical symptoms following influenza virus infection. Lett Appl Microbiol 58(1):87–93PubMedCrossRef Waki N, Yajima N, Suganuma H, Buddle BM, Luo D, Heiser A, Zheng T (2014) Oral administration of Lactobacillus brevis KB290 to mice alleviates clinical symptoms following influenza virus infection. Lett Appl Microbiol 58(1):87–93PubMedCrossRef
7.
go back to reference Falsey AR, Becker KL, Swinburne AJ, Nylen ES, Formica MA, Hennessey PA, Criddle MM, Peterson DR, Baran A, Walsh EE (2013) Bacterial complications of respiratory tract viral illness: a comprehensive evaluation. J Infect Dis 208(3):432–441PubMedCentralPubMedCrossRef Falsey AR, Becker KL, Swinburne AJ, Nylen ES, Formica MA, Hennessey PA, Criddle MM, Peterson DR, Baran A, Walsh EE (2013) Bacterial complications of respiratory tract viral illness: a comprehensive evaluation. J Infect Dis 208(3):432–441PubMedCentralPubMedCrossRef
8.
go back to reference Al-Kaabi N, Solh Z, Pacheco S, Murray L, Gaboury I, Le Saux N (2006) A comparison of group A Streptococcus versus Streptococcus pneumoniae pneumonia. Pediatr Infect Dis J 25(11):1008–1012PubMedCrossRef Al-Kaabi N, Solh Z, Pacheco S, Murray L, Gaboury I, Le Saux N (2006) A comparison of group A Streptococcus versus Streptococcus pneumoniae pneumonia. Pediatr Infect Dis J 25(11):1008–1012PubMedCrossRef
9.
go back to reference Reinton N, Manley L, Tjade T, Moghaddam A (2013) Respiratory tract infections during the 2011 Mycoplasma pneumoniae epidemic. Eur J Clin Microbiol Infect Dis 32(6):835–840PubMedCrossRef Reinton N, Manley L, Tjade T, Moghaddam A (2013) Respiratory tract infections during the 2011 Mycoplasma pneumoniae epidemic. Eur J Clin Microbiol Infect Dis 32(6):835–840PubMedCrossRef
10.
go back to reference R Development Core Team (2012) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna R Development Core Team (2012) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna
11.
go back to reference Renner ED, Helms CM, Johnson W, Tseng CH (1983) Coinfections of Mycoplasma pneumoniae and Legionella pneumophila with influenza A virus. J Clin Microbiol 17(1):146–148PubMedCentralPubMed Renner ED, Helms CM, Johnson W, Tseng CH (1983) Coinfections of Mycoplasma pneumoniae and Legionella pneumophila with influenza A virus. J Clin Microbiol 17(1):146–148PubMedCentralPubMed
12.
go back to reference Bezerra PG, Britto MC, Correia JB, Duarte Mdo C, Fonceca AM, Rose K, Hopkins MJ, Cuevas LE, McNamara PS (2011) Viral and atypical bacterial detection in acute respiratory infection in children under five years. PLoS One 6(4):e18928PubMedCentralPubMedCrossRef Bezerra PG, Britto MC, Correia JB, Duarte Mdo C, Fonceca AM, Rose K, Hopkins MJ, Cuevas LE, McNamara PS (2011) Viral and atypical bacterial detection in acute respiratory infection in children under five years. PLoS One 6(4):e18928PubMedCentralPubMedCrossRef
13.
go back to reference Pientong C, Ekalaksananan T, Teeratakulpisarn J, Tanuwattanachai S, Kongyingyoes B, Limwattananon C (2011) Atypical bacterial pathogen infection in children with acute bronchiolitis in northeast Thailand. J Microbiol Immunol Infect 44(2):95–100PubMed Pientong C, Ekalaksananan T, Teeratakulpisarn J, Tanuwattanachai S, Kongyingyoes B, Limwattananon C (2011) Atypical bacterial pathogen infection in children with acute bronchiolitis in northeast Thailand. J Microbiol Immunol Infect 44(2):95–100PubMed
14.
go back to reference Lieberman D, Shvartzman P, Lieberman D, Ben-Yaakov M, Lazarovich Z, Hoffman S, Mosckovitz R, Ohana B, Leinonen M, Luffy D, Boldur I (1998) Etiology of respiratory tract infection in adults in a general practice setting. Eur J Clin Microbiol Infect Dis 17(10):685–689PubMedCrossRef Lieberman D, Shvartzman P, Lieberman D, Ben-Yaakov M, Lazarovich Z, Hoffman S, Mosckovitz R, Ohana B, Leinonen M, Luffy D, Boldur I (1998) Etiology of respiratory tract infection in adults in a general practice setting. Eur J Clin Microbiol Infect Dis 17(10):685–689PubMedCrossRef
15.
go back to reference Freymuth F, Vabret A, Brouard J, Toutain F, Verdon R, Petitjean J, Gouarin S, Duhamel JF, Guillois B (1999) Detection of viral, Chlamydia pneumoniae and Mycoplasma pneumoniae infections in exacerbations of asthma in children. J Clin Virol 13(3):131–139PubMedCrossRef Freymuth F, Vabret A, Brouard J, Toutain F, Verdon R, Petitjean J, Gouarin S, Duhamel JF, Guillois B (1999) Detection of viral, Chlamydia pneumoniae and Mycoplasma pneumoniae infections in exacerbations of asthma in children. J Clin Virol 13(3):131–139PubMedCrossRef
16.
go back to reference Fransen F, Stenger RM, Poelen MC, van Dijken HH, Kuipers B, Boog CJ, van Putten JP, van Els CA, van der Ley P (2010) Differential effect of TLR2 and TLR4 on the immune response after immunization with a vaccine against Neisseria meningitidis or Bordetella pertussis. PLoS One 5(12):e15692PubMedCentralPubMedCrossRef Fransen F, Stenger RM, Poelen MC, van Dijken HH, Kuipers B, Boog CJ, van Putten JP, van Els CA, van der Ley P (2010) Differential effect of TLR2 and TLR4 on the immune response after immunization with a vaccine against Neisseria meningitidis or Bordetella pertussis. PLoS One 5(12):e15692PubMedCentralPubMedCrossRef
17.
go back to reference Love W, Dobbs N, Tabor L, Simecka JW (2010) Toll-like receptor 2 (TLR2) plays a major role in innate resistance in the lung against murine Mycoplasma. PLoS One 5(5):e10739PubMedCentralPubMedCrossRef Love W, Dobbs N, Tabor L, Simecka JW (2010) Toll-like receptor 2 (TLR2) plays a major role in innate resistance in the lung against murine Mycoplasma. PLoS One 5(5):e10739PubMedCentralPubMedCrossRef
18.
go back to reference Chu HW, Jeyaseelan S, Rino JG, Voelker DR, Wexler RB, Campbell K, Harbeck RJ, Martin RJ (2005) TLR2 signaling is critical for Mycoplasma pneumoniae-induced airway mucin expression. J Immunol 174(9):5713–5719PubMedCrossRef Chu HW, Jeyaseelan S, Rino JG, Voelker DR, Wexler RB, Campbell K, Harbeck RJ, Martin RJ (2005) TLR2 signaling is critical for Mycoplasma pneumoniae-induced airway mucin expression. J Immunol 174(9):5713–5719PubMedCrossRef
19.
go back to reference Prebeck S, Kirschning C, Dürr S, da Costa C, Donath B, Brand K, Redecke V, Wagner H, Miethke T (2001) Predominant role of toll-like receptor 2 versus 4 in Chlamydia pneumoniae-induced activation of dendritic cells. J Immunol 167(6):3316–3323PubMedCrossRef Prebeck S, Kirschning C, Dürr S, da Costa C, Donath B, Brand K, Redecke V, Wagner H, Miethke T (2001) Predominant role of toll-like receptor 2 versus 4 in Chlamydia pneumoniae-induced activation of dendritic cells. J Immunol 167(6):3316–3323PubMedCrossRef
20.
go back to reference Tuvim MJ, Gilbert BE, Dickey BF, Evans SE (2012) Synergistic TLR2/6 and TLR9 activation protects mice against lethal influenza pneumonia. PLoS One 7(1):e30596PubMedCentralPubMedCrossRef Tuvim MJ, Gilbert BE, Dickey BF, Evans SE (2012) Synergistic TLR2/6 and TLR9 activation protects mice against lethal influenza pneumonia. PLoS One 7(1):e30596PubMedCentralPubMedCrossRef
21.
go back to reference Tan AC, Mifsud EJ, Zeng W, Edenborough K, McVernon J, Brown LE, Jackson DC (2012) Intranasal administration of the TLR2 agonist Pam2Cys provides rapid protection against influenza in mice. Mol Pharm 9(9):2710–2718PubMedCrossRef Tan AC, Mifsud EJ, Zeng W, Edenborough K, McVernon J, Brown LE, Jackson DC (2012) Intranasal administration of the TLR2 agonist Pam2Cys provides rapid protection against influenza in mice. Mol Pharm 9(9):2710–2718PubMedCrossRef
Metadata
Title
Estimating the prevalence of coinfection with influenza virus and the atypical bacteria Bordetella pertussis, Chlamydophila pneumoniae, and Mycoplasma pneumoniae
Authors
M. J. Mina
R. M. Burke
K. P. Klugman
Publication date
01-09-2014
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 9/2014
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-014-2120-0

Other articles of this Issue 9/2014

European Journal of Clinical Microbiology & Infectious Diseases 9/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine